-
1
-
-
0028237729
-
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
-
Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-23.
-
(1994)
J Pharmacol Exp Ther
, vol.270
, pp. 414-423
-
-
Shimada, T.1
Yamazaki, H.2
Mimura, M.3
Inui, Y.4
Guengerich, F.P.5
-
2
-
-
0029131555
-
Clinical importance of hepatic cytochrome P450 in drug metabolism
-
Spatzenegger M, Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev 1995;27:397-417.
-
(1995)
Drug Metab Rev
, vol.27
, pp. 397-417
-
-
Spatzenegger, M.1
Jaeger, W.2
-
3
-
-
0028336794
-
Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: Absence of mutation prescribing the phenotype in the CYP1A2 gene
-
Nakajima M, Yokoi T, Mizutani M, Shin S, Kadlubar FF, Kamataki T. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol Biomarkers Prev 1994;3:413-21.
-
(1994)
Cancer Epidemiol Biomarkers Prev
, vol.3
, pp. 413-421
-
-
Nakajima, M.1
Yokoi, T.2
Mizutani, M.3
Shin, S.4
Kadlubar, F.F.5
Kamataki, T.6
-
4
-
-
0026094528
-
Use of caffeine metabolic ratios to explore CYP1A2 and xanthine oxidase activities
-
Kalow W, Tang BK. Use of caffeine metabolic ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 1991;50:508-19.
-
(1991)
Clin Pharmacol Ther
, vol.50
, pp. 508-519
-
-
Kalow, W.1
Tang, B.K.2
-
5
-
-
0026879487
-
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
-
Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, et al. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 1992;2:116-27.
-
(1992)
Pharmacogenetics
, vol.2
, pp. 116-127
-
-
Butler, M.A.1
Lang, N.P.2
Young, J.F.3
Caporaso, N.E.4
Vineis, P.5
Hayes, R.B.6
-
6
-
-
0021813284
-
N-Acetylation pharmacogenetics
-
Weber WW, Hein DW. N-Acetylation pharmacogenetics. Pharmacol Rev 1985;37:25-79.
-
(1985)
Pharmacol Rev
, vol.37
, pp. 25-79
-
-
Weber, W.W.1
Hein, D.W.2
-
7
-
-
0002202499
-
N-Acetyltransferase
-
Kalow W, editor. New York: Pergamon Press
-
Evans DAP. N-Acetyltransferase. In: Kalow W, editor. Pharmacogenetics of drug metabolism. New York: Pergamon Press; 1992. p. 95-178.
-
(1992)
Pharmacogenetics of Drug Metabolism
, pp. 95-178
-
-
Evans, D.A.P.1
-
8
-
-
0021798210
-
Genetically determined variability in acetylation and oxidation: Therapeutic implications
-
Clark DWJ. Genetically determined variability in acetylation and oxidation: therapeutic implications. Drugs 1985;29:342-75.
-
(1985)
Drugs
, vol.29
, pp. 342-375
-
-
Clark, D.W.J.1
-
10
-
-
0019990268
-
Ethnic differences in drug metabolism
-
Kalow W. Ethnic differences in drug metabolism. Clin Pharmacokinet 1982;7:373-400.
-
(1982)
Clin Pharmacokinet
, vol.7
, pp. 373-400
-
-
Kalow, W.1
-
11
-
-
0017398371
-
Clinical consequences of polymorphic acetylation of basic drugs
-
Drayer DE, Reidenberg MM. Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther 1977;22:251-8.
-
(1977)
Clin Pharmacol Ther
, vol.22
, pp. 251-258
-
-
Drayer, D.E.1
Reidenberg, M.M.2
-
12
-
-
0019976311
-
Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
-
Cartwright RA, Glasham RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, et al. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982;2:842-6.
-
(1982)
Lancet
, vol.2
, pp. 842-846
-
-
Cartwright, R.A.1
Glasham, R.W.2
Rogers, H.J.3
Ahmad, R.A.4
Barham-Hall, D.5
Higgins, E.6
-
13
-
-
0024235283
-
Genetic polymorphism and cancer susceptibility: Evidence concerning acetyltransferases and cancer of the urinary bladder
-
Hein DW. Genetic polymorphism and cancer susceptibility: evidence concerning acetyltransferases and cancer of the urinary bladder. Bioessays 1988;9:200-4.
-
(1988)
Bioessays
, vol.9
, pp. 200-204
-
-
Hein, D.W.1
-
14
-
-
0016281733
-
A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase
-
Kretnitsky TA, Tuttle JV, Cattau EL, Wang P. A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp Biochem Physiol 1974;49B:687-703.
-
(1974)
Comp Biochem Physiol
, vol.49 B
, pp. 687-703
-
-
Kretnitsky, T.A.1
Tuttle, J.V.2
Cattau, E.L.3
Wang, P.4
-
15
-
-
0022001353
-
Variability of caffeine metabolism in humans
-
Kalow W. Variability of caffeine metabolism in humans. Drug Res 1985;35:319-24.
-
(1985)
Drug Res
, vol.35
, pp. 319-324
-
-
Kalow, W.1
-
17
-
-
0023227456
-
A urinary metabolite ratio that reflects systemic caffeine clearance
-
Campell ME, Spielberg SP, Kalow W. A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 1987;42:157-65.
-
(1987)
Clin Pharmacol Ther
, vol.42
, pp. 157-165
-
-
Campell, M.E.1
Spielberg, S.P.2
Kalow, W.3
-
18
-
-
0021151820
-
A simple test for acetylator phenotype using caffeine
-
Grant DM, Tang BK, Kalow W. A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol 1984;17:459-64.
-
(1984)
Br J Clin Pharmacol
, vol.17
, pp. 459-464
-
-
Grant, D.M.1
Tang, B.K.2
Kalow, W.3
-
20
-
-
0027922323
-
Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs
-
Food and Drug Administration. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs. Federal Register 1993;58:39406-16.
-
(1993)
Federal Register
, vol.58
, pp. 39406-39416
-
-
-
21
-
-
0021322739
-
Sex related differences in drug disposition in man
-
Wilson K. Sex related differences in drug disposition in man. Clin Pharmacokinet 1984;9:189-202.
-
(1984)
Clin Pharmacokinet
, vol.9
, pp. 189-202
-
-
Wilson, K.1
-
22
-
-
0029128720
-
Gender effects in pharmacokinetics and pharmacodynamics
-
Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50:222-39.
-
(1995)
Drugs
, vol.50
, pp. 222-239
-
-
Harris, R.Z.1
Benet, L.Z.2
Schwartz, J.B.3
-
23
-
-
0026621673
-
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities
-
Relling MV, Lin JS, Ayers GD, Evans WE. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther 1992;52:643-58.
-
(1992)
Clin Pharmacol Ther
, vol.52
, pp. 643-658
-
-
Relling, M.V.1
Lin, J.S.2
Ayers, G.D.3
Evans, W.E.4
-
24
-
-
0029061221
-
A study of gender-based cytochrome P4501A2 variability: A possible mechanism for the male excess of bladder cancer
-
Horn EP, Tucker MA, Lambert G, Silverman D, Zametkin D, Sinha R, et al. A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer. Cancer Epidemiol Biomarkers Prev 1995;4:529-33.
-
(1995)
Cancer Epidemiol Biomarkers Prev
, vol.4
, pp. 529-533
-
-
Horn, E.P.1
Tucker, M.A.2
Lambert, G.3
Silverman, D.4
Zametkin, D.5
Sinha, R.6
-
25
-
-
0029769679
-
The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: A comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate
-
Bartoli A, Xiaodong S, Gatti G, Cipolla G, Marchiselli R, Perucca E. The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate. Ther Drug Monit 1996;18:586-91.
-
(1996)
Ther Drug Monit
, vol.18
, pp. 586-591
-
-
Bartoli, A.1
Xiaodong, S.2
Gatti, G.3
Cipolla, G.4
Marchiselli, R.5
Perucca, E.6
-
27
-
-
0025312801
-
Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics
-
Bruguerolle B, Toumi M, Faraj F, Vervloet D, Razzouk H. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics. Eur J Clin Pharmacol 1990;39:59-61.
-
(1990)
Eur J Clin Pharmacol
, vol.39
, pp. 59-61
-
-
Bruguerolle, B.1
Toumi, M.2
Faraj, F.3
Vervloet, D.4
Razzouk, H.5
-
28
-
-
0018411742
-
Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases
-
Wojciki J, Gawronska-Szklarz B, Kazimierczyk J, Baskiewicz Z, Raczynski A. Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases. Arzneimittelforschung 1979;29: 350-2.
-
(1979)
Arzneimittelforschung
, vol.29
, pp. 350-352
-
-
Wojciki, J.1
Gawronska-Szklarz, B.2
Kazimierczyk, J.3
Baskiewicz, Z.4
Raczynski, A.5
-
29
-
-
0021858734
-
Distribution of acetylator phenotype in relation to age and sex in Swedish patients
-
Paulsen O, Nilsson LG. Distribution of acetylator phenotype in relation to age and sex in Swedish patients. Eur J Clin Pharmacol 1985;28:311-5.
-
(1985)
Eur J Clin Pharmacol
, vol.28
, pp. 311-315
-
-
Paulsen, O.1
Nilsson, L.G.2
-
30
-
-
0023274984
-
Influence of age, sex and body weight on the dapsone acetylation phenotype
-
Philip PA, Gayed SL, Rogers HJ, Crome P. Influence of age, sex and body weight on the dapsone acetylation phenotype. Br J Clin Pharmacol 1987;23:709-13.
-
(1987)
Br J Clin Pharmacol
, vol.23
, pp. 709-713
-
-
Philip, P.A.1
Gayed, S.L.2
Rogers, H.J.3
Crome, P.4
-
31
-
-
0030951759
-
Acetylator phenotype in relation to age and gender in the Baltimore longitudinal study of aging
-
Korrapati MR, Sorkin JD, Andres R, Muller CD, Loe C, Vesell ES, et al. Acetylator phenotype in relation to age and gender in the Baltimore longitudinal study of aging. J Clin Pharmacol 1997;37:83-91.
-
(1997)
J Clin Pharmacol
, vol.37
, pp. 83-91
-
-
Korrapati, M.R.1
Sorkin, J.D.2
Andres, R.3
Muller, C.D.4
Loe, C.5
Vesell, E.S.6
-
32
-
-
0028333956
-
Caffeine as a probe for CYP1A2 activity: Potential influence of renal factors on urinary phenotypic trait measurements
-
Tang KB, Zhou Y, Kadar D, Kalow W. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements. Pharmacogenetics 1994;4:117-24.
-
(1994)
Pharmacogenetics
, vol.4
, pp. 117-124
-
-
Tang, K.B.1
Zhou, Y.2
Kadar, D.3
Kalow, W.4
-
33
-
-
0019362251
-
Introduction to sample size determination and power analysis for clinical trials
-
Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981;2:93-113.
-
(1981)
Control Clin Trials
, vol.2
, pp. 93-113
-
-
Lachin, J.M.1
-
34
-
-
0024379208
-
Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children
-
Evans WH, Relling MV, Petros WP, Meyer WH, Mirro J Jr, Crom WR. Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children. Clin Pharmacol Ther 1989;45:568-73.
-
(1989)
Clin Pharmacol Ther
, vol.45
, pp. 568-573
-
-
Evans, W.H.1
Relling, M.V.2
Petros, W.P.3
Meyer, W.H.4
Mirro Jr., J.5
Crom, W.R.6
-
36
-
-
0025892853
-
Caffeine as a metabolic probe: Validation of its use for acetylator phenotyping
-
Tang BK, Kadar D, Qian L, Iriah J, Yip J, Kalow W. Caffeine as a metabolic probe: validation of its use for acetylator phenotyping. Clin Pharmacol Ther 1991;49:648-57.
-
(1991)
Clin Pharmacol Ther
, vol.49
, pp. 648-657
-
-
Tang, B.K.1
Kadar, D.2
Qian, L.3
Iriah, J.4
Yip, J.5
Kalow, W.6
-
37
-
-
7844249176
-
-
Evanston (IL): SYSTAT Intelligent Software
-
SYSTAT user's guide. Evanston (IL): SYSTAT Intelligent Software; 1990.
-
(1990)
SYSTAT User's Guide
-
-
-
38
-
-
0016278917
-
Gentamicin pharmacokinetics
-
Devine BJ. Gentamicin pharmacokinetics. Drug Intell Clin Pharm 1974;8:650-5.
-
(1974)
Drug Intell Clin Pharm
, vol.8
, pp. 650-655
-
-
Devine, B.J.1
-
39
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Cockcroft DW, Gault MDH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.D.H.2
-
40
-
-
0025055648
-
Enzyme induction in the cytochrome P-450 system
-
Okey AB. Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 1990;45:241-98.
-
(1990)
Pharmacol Ther
, vol.45
, pp. 241-298
-
-
Okey, A.B.1
|